First Trust Advisors’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

First Trust Advisors’s Portfolio MR Stock Details MR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-56,453	Closed	-$1.53M	–	2366
2015 Q4	$1.53M	Sell	56,453 -9,056	-14%	-$233K	﹤0.01%	1553
2015 Q3	$1.43M	Sell	65,509 -20,875	-24%	-$533K	﹤0.01%	1566
2015 Q2	$2.46M	Buy	86,384 +50,211	+139%	+$1.46M	0.01%	1406
2015 Q1	$989K	Buy	36,173 +7,250	+25%	+$200K	﹤0.01%	1758
2014 Q4	$764K	Buy	28,923 +11,985	+71%	+$351K	﹤0.01%	1829
2014 Q3	$511K	Buy	16,938 +835	+5%	+$25.9K	﹤0.01%	1924
2014 Q2	$507K	Buy	16,103 +2,906	+22%	+$92.2K	﹤0.01%	1907
2014 Q1	$427K	Sell	13,197 -1,468	-10%	-$51.4K	﹤0.01%	1982
2013 Q4	$533K	Buy	14,665 +4,240	+41%	+$165K	﹤0.01%	1871
2013 Q3	$405K	Sell	10,425 -529	-5%	-$21.3K	﹤0.01%	1994
2013 Q2	$410K	Buy	+10,954	New	+$433K	﹤0.01%	1902

Other funds holding MR

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

First Trust Advisors's MR Position: Q1 2016 in Review

First Trust Advisors sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 56,453 shares — an estimated $1.53M sold.

First Trust Advisors first reported a position in MR in Q2 2013 and held it in 11 quarters. The position peaked at $2.46M in Q2 2015. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

First Trust Advisors reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
First Trust Advisors sold 56,453 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $1.53M.
First Trust Advisors first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 11 quarters.
First Trust Advisors's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $2.46M in Q2 2015.
2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on First Trust Advisors's 13F filing for Q1 2016, filed 10 May 2016.